Pliant Therapeutics, Inc.
PLRX
$1.15
$0.021.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.63% | 15.00% | 10.36% | 39.26% | 22.91% |
| Total Depreciation and Amortization | -5.68% | -27.67% | -16.28% | -2.46% | -0.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.26% | -27.48% | -0.89% | -17.88% | -17.30% |
| Change in Net Operating Assets | 190.73% | -138.60% | 25.75% | 60.32% | -63.44% |
| Cash from Operations | 33.45% | -8.10% | 15.62% | 48.08% | 16.91% |
| Capital Expenditure | -- | -- | -- | 100.00% | 57.25% |
| Sale of Property, Plant, and Equipment | -83.33% | 10,300.00% | -100.64% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 468.23% | -337.54% | -93.63% | -22.01% | -48.69% |
| Cash from Investing | 477.80% | -331.90% | -93.67% | -21.32% | -48.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 100.23% | -44,915.28% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.58% | 51.84% | -798.60% | 235.11% | -124.66% |